scholarly journals Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

2017 ◽  
Vol 8 (1) ◽  
Author(s):  
HaoRan Tang ◽  
Leo Leung ◽  
Grazia Saturno ◽  
Amaya Viros ◽  
Duncan Smith ◽  
...  
Keyword(s):  
Cell Surface ◽  
Therapeutic Potential ◽  
Lysyl Oxidase ◽  
Tumour Progression ◽  
Growth Factor Receptor ◽  
Tumour Microenvironment ◽  
Metastatic Tumour ◽  
Egf Receptors ◽  
Molecule Inhibitor

Abstract Lysyl oxidase (LOX) remodels the tumour microenvironment by cross-linking the extracellular matrix. LOX overexpression is associated with poor cancer outcomes. Here, we find that LOX regulates the epidermal growth factor receptor (EGFR) to drive tumour progression. We show that LOX regulates EGFR by suppressing TGFβ1 signalling through the secreted protease HTRA1. This increases the expression of Matrilin2 (MATN2), an EGF-like domain-containing protein that traps EGFR at the cell surface to facilitate its activation by EGF. We describe a pharmacological inhibitor of LOX, CCT365623, which disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumour cells in vivo. Thus, we show that LOX regulates EGFR cell surface retention to drive tumour progression, and we validate the therapeutic potential of inhibiting this pathway with the small molecule inhibitor CCT365623.

scholarly journals Author Correction: Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface

2019 ◽  
Vol 10 (1) ◽  
Author(s):  
HaoRan Tang ◽  
Leo Leung ◽  
Grazia Saturno ◽  
Amaya Viros ◽  
Duncan Smith ◽  
...  
Keyword(s):  
Cell Surface ◽  
Lysyl Oxidase ◽  
Tumour Progression ◽  
Egf Receptors

scholarly journals Cell surface annexins regulate ADAM-mediated ectodomain shedding of proamphiregulin

2012 ◽  
Vol 23 (10) ◽  
pp. 1964-1975 ◽  
Author(s):  
Hironao Nakayama ◽  
Shinji Fukuda ◽  
Hirofumi Inoue ◽  
Hisayo Nishida-Fukuda ◽  
Yuji Shirakata ◽  
...  
Keyword(s):  
Cell Surface ◽  
Therapeutic Potential ◽  
Growth Factor Receptor ◽  
Ultraviolet B ◽  
Ectodomain Shedding ◽  
Substrate Selectivity ◽  
Primary Keratinocytes ◽  
Egfr Ligands ◽  
Epidermal Growth ◽  
A Disintegrin And Metalloproteinase

A disintegrin and metalloproteinase (ADAM) is a family of enzymes involved in ectodomain shedding of various membrane proteins. However, the molecular mechanism underlying substrate recognition by ADAMs remains unknown. In this study, we successfully captured and analyzed cell surface transient assemblies between the transmembrane amphiregulin precursor (proAREG) and ADAM17 during an early shedding phase, which enabled the identification of cell surface annexins as components of their shedding complex. Annexin family members annexin A2 (ANXA2), A8, and A9 interacted with proAREG and ADAM17 on the cell surface. Shedding of proAREG was increased when ANXA2 was knocked down but decreased with ANXA8 and A9 knockdown, because of enhanced and impaired association with ADAM17, respectively. Knockdown of ANXA2 and A8 in primary keratinocytes altered wound-induced cell migration and ultraviolet B–induced phosphorylation of epidermal growth factor receptor (EGFR), suggesting that annexins play an essential role in the ADAM-mediated ectodomain shedding of EGFR ligands. On the basis of these data, we propose that annexins on the cell surface function as “shedding platform” proteins to determine the substrate selectivity of ADAM17, with possible therapeutic potential in ADAM-related diseases.

scholarly journals Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential

2021 ◽  
Vol 12 (3) ◽  
Author(s):  
Shuai Huang ◽  
Bihui Cao ◽  
Jinling Zhang ◽  
Yunfei Feng ◽  
Lu Wang ◽  
...  
Keyword(s):  
Molecular Mechanism ◽  
Molecular Mechanisms ◽  
Therapeutic Potential ◽  
Tumour Progression ◽  
Biological Activities ◽  
Nasopharyngeal Cancer ◽  
Migration And Invasion ◽  
Cucurbitacin B

AbstractCucurbitacin B (CuB) is a widely available triterpenoid molecule that exhibits various biological activities. Previous studies on the anti-tumour mechanism of CuB have mostly focused on cell apoptosis, and research on the ferroptosis-inducing effect has rarely been reported. Herein, we first discovered the excellent cytotoxicity of CuB towards human nasopharyngeal carcinoma cells and elucidated its potential ferroptosis-inducing mechanisms. Morphology alterations of mitochondrial ultrastructure, as observed via transmission electron microscopy, showed that CuB-treated cells undergo ferroptosis. CuB caused intracellular accumulation of iron ions and depletion of glutathione. Detailed molecular mechanism investigation confirmed that CuB both induced widespread lipid peroxidation and downregulated the expression of GPX4, ultimately initiating a multipronged mechanism of ferroptosis. Furthermore, CuB exhibited anti-tumour effects in vitro by inhibiting cellular microtubule polymerization, arresting cell cycle and suppressing migration and invasion. Finally, CuB significantly inhibited tumour progression without causing obvious side effects in vivo. Altogether, our study highlighted the therapeutic potential of CuB as a ferroptosis-inducing agent for nasopharyngeal cancer, and it provided valuable insights for developing effective anti-tumour agents with novel molecular mechanisms derived from natural products.

scholarly journals Tumour vessel remodelling: new opportunities in cancer treatment

2020 ◽  
Vol 2 (1) ◽  
pp. R35-R43
Author(s):  
Ruth Ganss
Keyword(s):  
Tumour Microenvironment ◽  
Metastatic Tumour ◽  
Full Potential ◽  
Functional Rehabilitation ◽  
Angiogenic Therapy ◽  
Transient Nature ◽  
Tumour Vasculature ◽  
Attractive Therapeutic Target ◽  
Tumour Vessel

Tumour growth critically depends on a supportive microenvironment, including the tumour vasculature. Tumour blood vessels are structurally abnormal and functionally anergic which limits drug access and immune responses in solid cancers. Thus, tumour vasculature has been considered an attractive therapeutic target for decades. However, with time, anti-angiogenic therapy has evolved from destruction to structural and functional rehabilitation as understanding of tumour vascular biology became more refined. Vessel remodelling or normalisation strategies which alleviate hypoxia are now coming of age having been shown to have profound effects on the tumour microenvironment. This includes improved tumour perfusion, release from immune suppression and lower metastasis rates. Nevertheless, clinical translation has been slow due to challenges such as the transient nature of current normalisation strategies, limited in vivo monitoring and the heterogeneity of primary and/or metastatic tumour environments, calling for more tailored approaches to vascular remodelling. Despite these setbacks, harnessing vascular plasticity provides unique opportunities for anti-cancer combination therapies in particular anti-angiogenic immunotherapy which are yet to reach their full potential.

scholarly journals Novel NFκB Inhibitor SC75741 Mitigates Chondrocyte Degradation and Prevents Activated Fibroblast Transformation by Modulating miR-21/GDF-5/SOX5 Signaling

2021 ◽  
Vol 22 (20) ◽  
pp. 11082
Author(s):  
Pei-Wei Weng ◽  
Vijesh Kumar Yadav ◽  
Narpati Wesa Pikatan ◽  
Iat-Hang Fong ◽  
I-Hsin Lin ◽  
...  
Keyword(s):  
Therapeutic Potential ◽  
Protective Role ◽  
Enzyme Linked Immunosorbent Assay ◽  
Molecule Inhibitor ◽  
Tnf Α ◽  
Inflammatory Profile ◽  
Fibroblast Transformation ◽  
Tgf Β1

Osteoarthritis (OA) is a common articular disease manifested by the destruction of cartilage and compromised chondrogenesis in the aging population, with chronic inflammation of synovium, which drives OA progression. Importantly, the activated synovial fibroblast (AF) within the synovium facilitates OA through modulating key molecules, including regulatory microRNAs (miR’s). To understand OA associated pathways, in vitro co-culture system, and in vivo papain-induced OA model were applied for this study. The expression of key inflammatory markers both in tissue and blood plasma were examined by qRT-PCR, western blot, immunohistochemistry, enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assays. Herein, our result demonstrated, AF-activated human chondrocytes (AC) exhibit elevated NFκB, TNF-α, IL-6, and miR-21 expression as compared to healthy chondrocytes (HC). Importantly, AC induced the apoptosis of HC and inhibited the expression of chondrogenesis inducers, SOX5, TGF-β1, and GDF-5. NFκB is a key inflammatory transcription factor elevated in OA. Therefore, SC75741 (an NFκB inhibitor) therapeutic effect was explored. SC75741 inhibits inflammatory profile, protects AC-educated HC from apoptosis, and inhibits miR-21 expression, which results in the induced expression of GDF-5, SOX5, TGF-β1, BMPR2, and COL4A1. Moreover, ectopic miR-21 expression in fibroblast-like activated chondrocytes promoted osteoblast-mediated differentiation of osteoclasts in RW264.7 cells. Interestingly, in vivo study demonstrated SC75741 protective role, in controlling the destruction of the articular joint, through NFκB, TNF-α, IL-6, and miR-21 inhibition, and inducing GDF-5, SOX5, TGF-β1, BMPR2, and COL4A1 expression. Our study demonstrated the role of NFκB/miR-21 axis in OA progression, and SC75741′s therapeutic potential as a small-molecule inhibitor of miR-21/NFκB-driven OA progression.

scholarly journals Protein arginine methyltransferase 5 promotes metastasis via enhancing EGFR transcription and modulating AKT1 activation by methylation

2020 ◽  
Author(s):  
Lei Huang ◽  
Xiao-Ou Zhang ◽  
Odette Verdejo-Torres ◽  
Kim Wigglesworth ◽  
Xiaomei Sun ◽  
...  
Keyword(s):  
Epithelial Mesenchymal Transition ◽  
Metastatic Cancer ◽  
Growth Factor Receptor ◽  
Protein Arginine Methyltransferase ◽  
Arginine Methyltransferase ◽  
Mesenchymal Transition ◽  
Molecule Inhibitor ◽  
Wide Range ◽  
Protein Arginine Methyltransferase 5

AbstractProtein arginine methyltransferase 5 (PRMT5) regulates a wide range of physiological processes, including cancer cell proliferation and metastasis, by generating symmetric di-methyl-arginine marks on histones and non-histone proteins. Here, we report that PRMT5 directly regulates epidermal growth factor receptor (EGFR) transcription to control EGF stimulated EGFR signaling. Furthermore, PRMT5 modulates protein kinase B (AKT) activation by methylation of AKT1 Arg 15, which is required for its subsequent phosphorylation at AKT1 Thr 308 and Ser 473. The PRMT5/EGFR/AKT axis converges to regulate transcription factors ZEB1, SNAIL, and TWIST1 to promote the epithelial-mesenchymal transition (EMT), in the manner that EGFR and AKT1 compensate each other to support tumor cell invasion and metastasis. Inhibiting PRMT5 methyltransferase activity with a small molecule inhibitor attenuated primary tumor growth and prevented hepatic metastasis in aggressive in vivo tumor models. Collectively, our results support the use of PRMT5 based therapies for metastatic cancer.

scholarly journals Ligand-mediated autophosphorylation activity of the epidermal growth factor receptor during internalization.

1989 ◽  
Vol 109 (6) ◽  
pp. 2751-2760 ◽  
Author(s):  
W H Lai ◽  
P H Cameron ◽  
J J Doherty ◽  
B I Posner ◽  
J J Bergeron
Keyword(s):  
Electron Microscope ◽  
Cell Surface ◽  
Egf Receptor ◽  
Growth Factor Receptor ◽  
Receptor Complexes ◽  
Diminished Capacity ◽  
Epidermal Growth ◽  
Polyethylene Glycol Precipitation

The association of EGF with its receptor in endosomes isolated from rat liver homogenates was assessed biochemically by polyethylene glycol precipitation and morphologically by electron microscope radioautography. The proportion of receptor-bound ligand in endosomes at 15 min after the injection of doses of 0.1 and 1 microgram EGF/100 g body weight was 57%. This value increased to 77% for the dose of 10 micrograms EGF injected. Quantitative electron microscope radioautography carried out on endosomes isolated at 15 min after the injection of 10 micrograms 125I-EGF demonstrated that most radiolabel was over the endosomal periphery thereby indicating that ligand-receptor complexes were in the bounding membrane but not in intraluminal vesicles of the content. EGF receptor autophosphorylation activity during internalization was evaluated in plasmalemma and endosome fractions. This activity was markedly but transiently reduced on the cell surface shortly after the administration of saturating doses of EGF. The same activity, however, was augmented and prolonged in endosomes for up to 30 min after EGF injection. The transient desensitization of cell surface activity was not due to prior in vivo phosphorylation since receptor dephosphorylation in vitro failed to restore autophosphorylation activity. Transient desensitization of cell surface autophosphorylation activity coincided with a diminished capacity for endocytosis of 125I-EGF with endocytosis returning to normal after the restoration of cell surface autophosphorylation activity. The inhibition of cell surface autophosphorylation activity and the activation of endosomal autophosphorylation activity coincident with downregulation suggest that EGF receptor traffic is governed by ligand-regulated phosphorylation activity.

scholarly journals Endocytosis separates EGF receptors from endogenous fluorescently labeled HRas and diminishes receptor signaling to MAP kinases in endosomes

2016 ◽  
Vol 113 (8) ◽  
pp. 2122-2127 ◽  
Author(s):  
Itziar Pinilla-Macua ◽  
Simon C. Watkins ◽  
Alexander Sorkin
Keyword(s):  
Plasma Membrane ◽  
Cell Surface ◽  
Map Kinases ◽  
Fluorescent Protein ◽  
Growth Factor Receptor ◽  
Egf Receptors ◽  
Downstream Signaling ◽  
Transient Activation ◽  
Cell Surface Biotinylation ◽  
Signaling Axis

Signaling from epidermal growth factor receptor (EGFR) to extracellular-stimuli–regulated protein kinase 1/2 (ERK1/2) is proposed to be transduced not only from the cell surface but also from endosomes, although the role of endocytosis in this signaling pathway is controversial. Ras is the only membrane-anchored component in the EGFR–ERK signaling axis, and therefore, its location determines intracellular sites of downstream signaling. Hence, we labeled endogenous H-Ras (HRas) with mVenus fluorescent protein using gene editing in HeLa cells. mVenus-HRas was primarily located at the plasma membrane, and in small amounts in tubular recycling endosomes and associated vesicles. EGF stimulation resulted in fast but transient activation of mVenus-HRas. Although EGF:EGFR complexes were rapidly accumulated in endosomes together with the Grb2 adaptor, very little, if any, mVenus-HRas was detected in these endosomes. Interestingly, the activities of MEK1/2 and ERK1/2 remained high beyond the point of the physical separation of HRas from EGF:EGFR complexes and down-regulation of Ras activity. Paradoxically, this sustained MEK1/2 and ERK1/2 activation was dependent on the active EGFR kinase. Cell surface biotinylation and selective inactivation of surface EGFRs suggested that a small fraction of active EGFRs remaining in the plasma membrane is responsible for continuous signaling to MEK1/2 and ERK1/2. We propose that, under physiological conditions of cell stimulation, EGFR endocytosis serves to spatially separate EGFR–Grb2 complexes and Ras, thus terminating Ras-mediated signaling. However, sustained minimal activation of Ras by a small pool of active EGFRs in the plasma membrane is sufficient for extending MEK1/2 and ERK1/2 activities.

scholarly journals A chemically unmodified agonistic DNA with growth factor functionality for in vivo therapeutic application

2020 ◽  
Vol 6 (14) ◽  
pp. eaay2801 ◽  
Author(s):  
Ryosuke Ueki ◽  
Satoshi Uchida ◽  
Naoto Kanda ◽  
Naoki Yamada ◽  
Ayaka Ueki ◽  
...  
Keyword(s):  
Growth Factors ◽  
Growth Factor ◽  
Therapeutic Potential ◽  
Growth Factor Receptor ◽  
Liver Parenchyma ◽  
Therapeutic Effects ◽  
Target Tissue ◽  
Systemic Injection ◽  
High Production Cost

Although growth factors have great therapeutic potential because of their regenerative functions, they often have intrinsic drawbacks, such as low thermal stability and high production cost. Oligonucleotides have recently emerged as promising chemical entities for designing synthetic alternatives to growth factors. However, their applications in vivo have been recognized as a challenge because of their susceptibility to nucleases and limited distribution to a target tissue. Here, we present the first example of oligonucleotide-based growth factor mimetics that exerts therapeutic effects at a target tissue after systemic injection. The aptamer was designed to dimerize a growth factor receptor for its activation and mitigated the progression of Fas-induced fulminant hepatitis in a mouse model. This unprecedented functionality of the aptamer can be reasonably explained by its high nuclease stability and migration to the liver parenchyma. These mechanistic analyses provided insights for the successful application of aptamer-based receptor agonists.

scholarly journals Expression of TXNIP is associated with angiogenesis and postoperative relapse of conventional renal cell carcinoma

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Mate Meszaros ◽  
Maria Yusenko ◽  
Lilla Domonkos ◽  
Lehel Peterfi ◽  
Gyula Kovacs ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Tumour Cell ◽  
Nuclear Translocation ◽  
Tumour Progression ◽  
Hypoxia Inducible Factor ◽  
Tumour Microenvironment ◽  
Good Prognosis ◽  
Metastatic Tumour ◽  
Ros Generation ◽  
Antioxidative Function

AbstractOne of the common mediator of tumour progression is the oxidative stress induced by inflammatory tumour microenvironment (TME). Activated fibroblasts, local and immune cells produce reactive oxygen species (ROS) supporting tumour cell proliferation and pave the way for metastatic tumour growth. TXNIP regulates ROS generation by inhibiting the antioxidative function of thioredoxin (TXN). The shift of TXNIP/TXN balance towards overexpression of TXNIP is associated with proliferation of endothelial cells during tumor angiogenesis. The oxidative stress activates the hypoxia inducible factor-1 (HIF-1), which plays an important role in the biology of conventional RCC (cRCC). Under oxydative stress TXNIP interacts with NLRP3 inflammasome leading to maturation and secretion of inflammatory cytokine IL1β. To establish the role of TXNIP and downstream genes HIF1α and IL1β in the biology of cRCC, we have applied immunohistochemistry to multi-tissue arrays containing tumours of 691 patients without detectable metastases at the time of operation. We found that cRCC displaying a fine organised capillary network with nuclear translocation of TXNIP and expressing IL1β have a good prognosis. In contrary, we showed a significant correlation between cytoplasmic TXNIP expression, inefficient vascularisation by unorganized and tortuous vessels causing tumour cell necrosis and postoperative tumour relapse of cRCC.

Sign in / Sign up

Export Citation Format

Share Document